In today’s recent session, 0.5 million shares of the Precigen Inc (NASDAQ:PGEN) have been traded, and its beta is 1.64. Most recently the company’s share price was $1.69, and it changed around -$0.13 or -7.14% from the last close, which brings the market valuation of the company to $496.93M. PGEN at last check was trading at a discount to its 52-week high of $2.17, offering almost -28.4% off that amount. The share price’s 52-week low was $0.65, which indicates that the recent value has risen by an impressive 61.54% since then. We note from Precigen Inc’s average daily trading volume that its 10-day average is 1.31 million shares, with the 3-month average coming to 2.09 million.
Precigen Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.80. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended PGEN as a Hold, whereas 2 deemed it a Buy, and 1 rated it as Underweight. Precigen Inc is expected to report earnings per share of -0.08 for the current quarter.
Precigen Inc (NASDAQ:PGEN) trade information
Instantly PGEN has been showing red trend so far today with a performance of -7.14% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.9600 on recent trading dayincreased the stock’s daily price by 13.78%. The company’s shares are currently up 50.89% year-to-date, but still up 1.20% over the last five days. On the other hand, Precigen Inc (NASDAQ:PGEN) is -3.43% down in the 30-day period. We can see from the shorts that 21.57 million shares have been sold at a short interest cover period of 9.69 day(s).
The consensus price target as assigned by Wall Street analysts is $6, which translates to bulls needing to increase their stock price by 71.83% from its current value. Analyst projections state that PGEN is forecast to be at a low of $6 and a high of $6.
Precigen Inc (PGEN) estimates and forecasts
The year-over-year growth rate is expected to be 361.78%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 600k in revenue for the current quarter. 3 analysts expect Precigen Inc to make 600k in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 1.06M and 717k respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -43.66%. Forecasts for the next quarter put sales growth at -16.32%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 25.76%.
Precigen Inc (NASDAQ:PGEN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 9.97% of Precigen Inc shares, and 66.16% of them are in the hands of institutional investors. The stock currently has a share float of 73.49%. Precigen Inc stock is held by 176.0 institutions, with PATIENT CAPITAL MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 7.2017% of the shares, which is about 18.17 million shares worth $28.72 million.
BLACKROCK INC., with 4.1116% or 10.25 million shares worth $16.19 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Patient Opportunity Trust and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 14.4 shares worth $24.34 million, making up 4.90% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 5.45 shares worth around $9.22 million, which represents about 1.85% of the total shares outstanding.
